KR20130041384A - 종양 치료제로서의 이소포스포르아미드 머스타드 및 이의 동족체의 염 - Google Patents

종양 치료제로서의 이소포스포르아미드 머스타드 및 이의 동족체의 염 Download PDF

Info

Publication number
KR20130041384A
KR20130041384A KR1020137008506A KR20137008506A KR20130041384A KR 20130041384 A KR20130041384 A KR 20130041384A KR 1020137008506 A KR1020137008506 A KR 1020137008506A KR 20137008506 A KR20137008506 A KR 20137008506A KR 20130041384 A KR20130041384 A KR 20130041384A
Authority
KR
South Korea
Prior art keywords
compound
cancer
ipm
pharmaceutical composition
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020137008506A
Other languages
English (en)
Korean (ko)
Inventor
리 모간
Original Assignee
데크-테크 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 데크-테크 인코포레이티드 filed Critical 데크-테크 인코포레이티드
Publication of KR20130041384A publication Critical patent/KR20130041384A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/22—Amides of acids of phosphorus
    • C07F9/222—Amides of phosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020137008506A 2004-10-25 2005-10-25 종양 치료제로서의 이소포스포르아미드 머스타드 및 이의 동족체의 염 Withdrawn KR20130041384A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US62208704P 2004-10-25 2004-10-25
US60/622,087 2004-10-25
US67270705P 2005-04-18 2005-04-18
US60/672,707 2005-04-18
PCT/US2005/038523 WO2006047575A2 (en) 2004-10-25 2005-10-25 Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020077011864A Division KR101292026B1 (ko) 2004-10-25 2005-10-25 종양 치료제로서의 이소포스포르아미드 머스타드 및 이의동족체의 염

Publications (1)

Publication Number Publication Date
KR20130041384A true KR20130041384A (ko) 2013-04-24

Family

ID=35788704

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020137008506A Withdrawn KR20130041384A (ko) 2004-10-25 2005-10-25 종양 치료제로서의 이소포스포르아미드 머스타드 및 이의 동족체의 염
KR1020077011864A Expired - Fee Related KR101292026B1 (ko) 2004-10-25 2005-10-25 종양 치료제로서의 이소포스포르아미드 머스타드 및 이의동족체의 염

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020077011864A Expired - Fee Related KR101292026B1 (ko) 2004-10-25 2005-10-25 종양 치료제로서의 이소포스포르아미드 머스타드 및 이의동족체의 염

Country Status (17)

Country Link
US (4) US8232262B2 (cg-RX-API-DMAC7.html)
EP (3) EP1805192B1 (cg-RX-API-DMAC7.html)
JP (1) JP5336082B2 (cg-RX-API-DMAC7.html)
KR (2) KR20130041384A (cg-RX-API-DMAC7.html)
CN (3) CN101087800B (cg-RX-API-DMAC7.html)
AU (1) AU2005299385B2 (cg-RX-API-DMAC7.html)
CA (1) CA2585125C (cg-RX-API-DMAC7.html)
DK (2) DK2336140T3 (cg-RX-API-DMAC7.html)
ES (2) ES2565929T3 (cg-RX-API-DMAC7.html)
HK (1) HK1209752A1 (cg-RX-API-DMAC7.html)
IL (3) IL182752A (cg-RX-API-DMAC7.html)
NO (1) NO20072478L (cg-RX-API-DMAC7.html)
NZ (2) NZ589418A (cg-RX-API-DMAC7.html)
PL (1) PL1805192T3 (cg-RX-API-DMAC7.html)
PT (1) PT1805192E (cg-RX-API-DMAC7.html)
SI (1) SI1805192T1 (cg-RX-API-DMAC7.html)
WO (1) WO2006047575A2 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2585125C (en) 2004-10-25 2014-04-22 Lee Morgan Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
US7964583B2 (en) 2006-02-17 2011-06-21 Ziopharm Oncology, Inc. Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
KR20150139620A (ko) * 2007-04-06 2015-12-11 지오팜 온콜로지 인코포레이티드 이소포스포르아미드 머스타드의 염 및 이의 동족체
SG183657A1 (en) * 2008-07-31 2012-09-27 Ziopharm Oncology Inc Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof
WO2010099213A1 (en) 2009-02-24 2010-09-02 Dekk-Tec, Inc. Complexes of 4-hydroperoxy ifosfamide as anti-tumor agents
CN102659841B (zh) * 2012-04-24 2015-03-25 石家庄学院 多元酚磷酰胺衍生物及其制备方法与应用
US10172789B2 (en) 2013-01-24 2019-01-08 Palvella Therapeutics Llc Compositions for transdermal delivery of mTOR inhibitors
CN108348780A (zh) * 2015-09-10 2018-07-31 贝克顿·迪金森公司 用作用于环磷酰胺和异环磷酰胺的免疫分析的免疫原和分析缀合物的环磷酰胺类似物
WO2018129364A1 (en) 2017-01-06 2018-07-12 Palvella Therapeutics Llc Anhydrous compositions of mtor inhibitors and methods of use
EP3684944B1 (en) 2017-09-21 2025-01-01 Becton, Dickinson and Company Hazardous contaminant collection kit and rapid testing
CN111107939B (zh) 2017-09-21 2022-04-12 贝克顿·迪金森公司 引导有害污染物样品的收集的系统和模板及使用其的方法
USD859683S1 (en) 2017-09-21 2019-09-10 Becton, Dickinson And Company Collection device
JP7223749B2 (ja) 2017-09-21 2023-02-16 ベクトン・ディキンソン・アンド・カンパニー 危険汚染物質の試験における高ダイナミックレンジの分析器
EP3817743A4 (en) 2018-07-02 2022-07-06 Palvella Therapeutics, Inc. ANHYDROUS COMPOSITIONS OF MTOR INHIBITORS AND METHODS OF USE
WO2020068657A1 (en) * 2018-09-25 2020-04-02 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services 2'-halogenated-4'-thio-2'-deoxy-5-azacytidine analogs and use thereof
CN113383222A (zh) 2019-01-28 2021-09-10 贝克顿·迪金森公司 具有集成的拭子和测试装置的有害污染物收集装置
CN111973583A (zh) * 2020-07-29 2020-11-24 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 芹菜素在制备促进缺血超长随意皮瓣存活药物的作用
CN111943979B (zh) 2020-10-19 2020-12-22 南京卓康医药科技有限公司 一种异环磷酰胺中间体及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU427945A1 (ru) 1972-07-24 1974-05-15 Институт элементоорганических соединений СПОСОБ ПОЛУЧЕНИЯа ПОЛИФТОРАЛКИЛЗАМЕЩЕННЫХБЕНЗИЛДИХЛОРФОСФАТОВ
JPS5159886A (cg-RX-API-DMAC7.html) 1974-11-20 1976-05-25 Shionogi Seiyaku Kk
ZA851062B (en) * 1984-03-01 1985-11-27 Asta Werke Ag Chem Fab Salts of oxazaphosphorine derivatives and process for their production
PL264222A1 (en) * 1986-02-22 1988-04-14 Method of obtaining novel heterocyclic compounds with 2-(2-/n,n-bis-(2-chloroethyl)-diamido-phosphoryloxy/ethyl)group
US4841085A (en) * 1986-06-30 1989-06-20 Board Of Regents, University Of Texas System Aldophosphamides
US5055459A (en) * 1986-06-30 1991-10-08 Board Of Regents, The University Of Texas Selective elimination of malignant cells from bone marrow by bis (acyloxy) propylphosphoramidates
WO1993021173A1 (en) 1992-04-17 1993-10-28 Abbott Laboratories Taxol derivatives
US5468499A (en) * 1993-11-15 1995-11-21 Ohio State University Liposomes containing the salt of phosphoramide mustard and related compounds
US5912264A (en) 1997-03-03 1999-06-15 Bristol-Myers Squibb Company 6-halo-or nitrate-substituted paclitaxels
JP4629238B2 (ja) * 1999-05-24 2011-02-09 サザン・リサーチ・インスティテュート イソホスホアミドマスタード・アナログ及びその使用
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
AU2001248201B2 (en) 2000-04-13 2006-12-14 Hsc Research And Development Limited Partnership Compounds for modulating cell proliferation
DE10064312C2 (de) * 2000-12-22 2003-05-22 Degussa Cholinpyruvat-Hydrat, Verfahren zu dessen Herstellung, Cholinpyruvat-Hydrat enthaltende Formulierung sowie deren Verwendung
ATE350383T1 (de) 2002-08-23 2007-01-15 Sloan Kettering Inst Cancer Synthese von epothilonen, zwischenprodukte dafür, analoga und deren verwendungen
CA2585125C (en) * 2004-10-25 2014-04-22 Lee Morgan Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
KR20150139620A (ko) 2007-04-06 2015-12-11 지오팜 온콜로지 인코포레이티드 이소포스포르아미드 머스타드의 염 및 이의 동족체
SG183657A1 (en) * 2008-07-31 2012-09-27 Ziopharm Oncology Inc Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof

Also Published As

Publication number Publication date
EP1805192A2 (en) 2007-07-11
CN101087800A (zh) 2007-12-12
EP2336140A2 (en) 2011-06-22
DK2336140T3 (en) 2016-03-21
IL182752A0 (en) 2007-07-24
US8795659B2 (en) 2014-08-05
EP2336139A3 (en) 2012-01-04
NZ555323A (en) 2010-12-24
PT1805192E (pt) 2013-01-23
AU2005299385A1 (en) 2006-05-04
US8232262B2 (en) 2012-07-31
HK1100945A1 (en) 2007-11-16
WO2006047575A2 (en) 2006-05-04
US9346836B2 (en) 2016-05-24
ES2397165T3 (es) 2013-03-05
SI1805192T1 (sl) 2013-02-28
US20150152125A1 (en) 2015-06-04
EP2336139A2 (en) 2011-06-22
PL1805192T3 (pl) 2013-03-29
EP1805192B1 (en) 2012-10-17
EP2336140B1 (en) 2016-01-27
NZ589418A (en) 2012-03-30
US7678778B2 (en) 2010-03-16
AU2005299385B2 (en) 2011-06-16
WO2006047575A3 (en) 2006-08-10
NO20072478L (no) 2007-06-25
US20080267945A1 (en) 2008-10-30
KR101292026B1 (ko) 2013-08-01
CN101087800B (zh) 2015-01-07
HK1209752A1 (en) 2016-04-08
IL211936A (en) 2012-12-31
EP2336140A3 (en) 2012-01-11
JP2008517949A (ja) 2008-05-29
IL211935A0 (en) 2011-05-31
JP5336082B2 (ja) 2013-11-06
US20130149296A1 (en) 2013-06-13
IL182752A (en) 2012-09-24
CN103172662A (zh) 2013-06-26
CN104558023A (zh) 2015-04-29
IL211936A0 (en) 2011-05-31
CA2585125C (en) 2014-04-22
CA2585125A1 (en) 2006-05-04
DK1805192T3 (da) 2013-02-04
US20060089333A1 (en) 2006-04-27
KR20070121632A (ko) 2007-12-27
ES2565929T3 (es) 2016-04-07

Similar Documents

Publication Publication Date Title
US9346836B2 (en) Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
KR101505415B1 (ko) 이소포스포르아미드 머스타드의 염 및 이의 동족체
US9254298B2 (en) Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof
AU2011221388B2 (en) Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
US7964583B2 (en) Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
HK1185884A (en) Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
HK1100945B (en) Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

Comment text: Divisional Application for International Patent

Patent event code: PA01041R01D

Patent event date: 20130402

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20130502

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20130603

Patent event code: PE09021S01D

PC1202 Submission of document of withdrawal before decision of registration

Comment text: [Withdrawal of Procedure relating to Patent, etc.] Withdrawal (Abandonment)

Patent event code: PC12021R01D

Patent event date: 20130828

WITB Written withdrawal of application